市场调查报告书
商品编码
1481995
亚太地区维生素 K2 市场预测至 2030 年 - 区域分析 - 按产品、剂型、来源和应用Asia Pacific Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application |
亚太地区维生素K2市场预计将从2022年的2,005万美元成长到2030年的1.8793亿美元。
配销通路的拓展推动亚太地区维生素 K2 市场
扩大维生素 K2 的分销管道有助于让更多人群更容易获得这种必需营养素。与製造商密切合作,确保增加维生素 K2 产品的产量和供应,以满足不断增长的需求。透过与批发商建立关係,可以更容易地将这些物品分发给药房、保健品店、超市和专业补充剂店的商家。此外,客户可以透过在零售点查看产品展示和教育材料来了解维生素 K2 的价值。此外,与发展中经济体的电子商务公司和网路平台合作,为客户提供一种在线购买补充剂和其他含有维生素 K2 的物品的简单方法也至关重要。
此外,鼓励在日常膳食和饮料中添加维生素 K2 可以扩大补充剂市场,让喜欢营养饮食的人更容易获得它。与医生、营养师和营养师等医疗保健专家合作也很重要,因为这些专家可以建议患者服用维生素 K2 补充剂并推荐购买该产品的商店。这增加了对维生素 K2 的需求。因此,透过医疗管道扩大分销网络预计将为未来几年的市场成长提供充足的机会。
亚太地区维生素 K2 市场概况
亚太地区维生素 K2 市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。市场的成长归因于心血管疾病盛行率的增加以及成人和新生儿骨质疏鬆症骨变形病例的增加。然而,人们对维生素 K2 益处的认识有限,阻碍了市场的成长。由于老年人口增加、心血管疾病增加和创新产品供应等因素,预计亚太地区市场在预测期内将显着成长。亚太地区其他地区包括泰国、纽西兰、新加坡、缅甸、越南和菲律宾。上述国家为维生素 K2 市场提供了巨大的成长机会。
例如,2019年,根据新加坡长期照护体系适应人口老化的报告,该国14%的人口(即390万人)年龄在65岁或以上。到 2030 年,由于预期寿命的延长,预计这一数字将达到 25%,这种人口变化对国家的健康和护理需求具有深远的影响。此外,在新西兰,发生心房颤动的风险随着年龄的增长而增加,65 岁以上人口中约5% 发生心房颤动,80 岁以上人口中约10% 发生心房颤动。也有所增加。例如,马来西亚的医疗保健支出从2017年到2018年有所增加,2018年为427美元,比2017年增长12.22%。 ,反映10年年复合成长率率为6.6%。因此,这些因素预计将在预测期内(2022-2030年)促进市场成长。
亚太地区维生素 K2 市场收入及 2030 年预测(百万美元)
亚太地区维生素 K2 市场区隔
亚太地区维生素 K2 市场按产品、剂型、来源、应用和国家/地区进行细分。
根据产品,亚太地区维生素 K2 市场分为 MK-4、MK-7 和组合药物。 2022 年,MK-7 细分市场占据亚太地区维生素 K2 市场的最大份额。
根据剂型,亚太地区维生素 K2 市场分为胶囊和片剂、粉末和油。 2022 年,粉末细分市场占据亚太地区维生素 K2 市场的最大份额。
根据来源,亚太地区维生素 K2 市场分为天然维生素 K2 和合成维生素 K2。 2022 年,天然产品在亚太地区维生素 K2 市场中占据更大份额。
根据应用,亚太地区维生素 K2 市场分为药品、营养保健品和食品等。 2022 年,药品领域占据亚太地区维生素 K2 市场的最大份额。
按国家/地区划分,亚太地区维生素 K2 市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022 年,亚太地区其他地区将主导亚太地区维生素 K2 市场。
Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG、Novozymes AS 和 Seebio Biotech(上海)有限公司是亚太地区的一些领先公司维生素K2市场。
The Asia Pacific vitamin K2 market is expected to grow from US$ 20.05 million in 2022 to US$ 187.93 million by 2030. It is estimated to grow at a CAGR of 32.3% from 2022 to 2030.
Expansion of Distribution Channel Fuels Asia Pacific Vitamin K2 Market
Expanding the distribution channels for vitamin K2 can help improve the accessibility of this essential nutrient to a broader population. Working closely with manufacturers ensures increased production and supply of vitamin K2 products to meet the growing demand. The distribution of these items to merchants in pharmacies, health shops, supermarkets, and specialty supplement stores, can be made easier by forming relationships with wholesalers. Additionally, customers can be made aware of the value of vitamin K2 by viewing product displays and educational materials at retail locations. Also, it is critical to work with developing economies-based e-commerce companies and web-based platforms to provide customers with a simple way to buy supplements and other items containing vitamin K2 online.
Furthermore, encouraging the inclusion of vitamin K2 in everyday meals and drinks can broaden the market for supplements, making it more available to people preferring a nutritional diet. Working with healthcare experts such as doctors, nutritionists, and dietitians is also essential, as these experts can advise patients to take vitamin K2 supplements and recommend a store to buy the product. This is raising the demand for vitamin K2. Thus, the expansion of the distribution networks through medical channels is expected to provide ample opportunities for market growth in the coming years.
Asia Pacific Vitamin K2 Market Overview
The Asia Pacific Vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market in Asia Pacific is expected to witness significant growth during the forecast period due to factors such as rising elderly population, growing cardiovascular diseases, and innovative product availability. The Rest of Asia Pacific includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and the Philippines. The countries mentioned above offer significant growth opportunities for the vitamin K2 market.
For instance, in 2019, according to Singapore's long-term care system adapting to population aging report, 14% of the country's population (i.e., 3.9 million people) was aged 65 years or older. By 2030, it is expected to reach 25% due to rising life expectancy, and this demographic shift has profound implications for the country's health and care needs. Additionally, in New Zealand, the risk of developing AF increases with age and occurs in about 5% of the population over 65 years and about 10% of people older than 80. Moreover, healthcare expenditure has been observed to increase in these countries. For instance, Malaysia's healthcare spending increased from 2017 to 2018, accounting for US$ 427 in 2018, a 12.22% increase from 2017. Thailand's healthcare expenditure amounts to US$ 25.3 billion, and costs are expected to increase by US$ 47.9 billion by 2026, reflecting a 10-year compound annual growth rate of 6.6%. Therefore, such factors are expected to enhance the market growth during the forecast period (2022-2030).
Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Vitamin K2 Market Segmentation
The Asia Pacific vitamin K2 market is segmented into product, dosage forms, source, application, and country.
Based on product, the Asia Pacific vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on dosage forms, the Asia Pacific vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on source, the Asia Pacific vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Asia Pacific vitamin K2 market in 2022.
Based on application, the Asia Pacific vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on country, the Asia Pacific vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific vitamin K2 market in 2022.
Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, Novozymes AS, and Seebio Biotech (Shanghai) Co Ltd are some of the leading companies operating in the Asia Pacific vitamin K2 market.